Rhogam Attorneys

RhoGAM is a medical treatment that has nearly eliminated the risk of jaundice, hypotonia, and motormental retardation from Rh incompatibility between a mother and fetus. Rh incompatibility occurs when a woman without the Rh factor (a protein found on the red blood cells of most people), conceives a child who has the Rh factor. The mother's Rh negative blood will react against the Rh positive blood of her fetus and attack it with antibodies.

The RhoGAM injection halts the mother's immune system from responding to the Rh positive blood of her child as a foreign threat and attacking it with antibodies. RhoGAM is a preventive drug and in its current form offers huge benefits with very minor side effects.

The concern over RhoGAM is based on the fact that in its earlier form it contained thimerosal. Between1968 (when RhoGAM was first licensed) and April of 2001, RhoGAM contained the thimerosal preservative. Thimerosal contains ethylmercury and because methylmercury (another mercury based composition) has been found to cause severe health problems, ethylmercury is also being scrutinized. Both compositions are known to be neurotoxins. To date, no conclusive evidence has been found linking ethylmercury to neurodevelopmental disorders, but the FDA has treated thimerosal with caution.